Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome

M. Louise Markert, Marilyn J. Alexieff, Jie Li, Marcelle Sarzotti, Daniel A. Ozaki, Blythe H. Devlin, Debra A. Sedlak, Gregory D. Sempowski, Laura P. Hale, Henry E. Rice, Samuel M. Mahaffey, Michael A. Skinner

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

Complete DiGeorge syndrome is a fatal congenital disorder characterized by athymia, hypoparathyroidism, and heart defects. Less than half of patients are 22q11 hemizygous. The goal of this study was to assess if immune suppression followed by postnatal thymus transplantation would lead to T-cell function in 6 infant patients who had host T cells at the time of transplantation. All infants had fewer than 50 recent thymic emigrants (CD3+CD45RA +CD62L+) per cubic millimeter (mm3) and all had some proliferative response to the mitogen phytohemagglutinin. Four infants had rash, lymphadenopathy, and oligoclonal populations of T cells in the periphery. Five of 6 patients are alive at the follow-up interval of 15 months to 30 months. The 5 surviving patients developed a mean of 983 host CD3+ T cells/ mm3 (range, 536/mm3-1574/mm3), a mean of 437 recent thymic emigrants/mm3 (range, 196/mm3-785/ mm3), and normal proliferative responses to phytohemaglutinin (follow-up from day 376 to day 873). The TCR repertoire became polyclonal in patients who presented with oligoclonal T cells. All patients had thymopoiesis on allograft biopsy. Postnatal thymus transplantation after treatment with Thymoglobulin shows promise as therapy for infants with complete DiGeorge syndrome who have significant proliferative responses to mitogens or who develop rash, lymphadenopathy, and oligoclonal T cells.

Original languageEnglish (US)
Pages (from-to)2574-2581
Number of pages8
JournalBlood
Volume104
Issue number8
DOIs
StatePublished - Oct 15 2004

Fingerprint

DiGeorge Syndrome
Thymus
T-cells
Immunosuppression
Thymus Gland
Transplantation
T-Lymphocytes
Exanthema
Mitogens
Therapeutics
Hypoparathyroidism
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Biopsy
Phytohemagglutinins
Allografts
Defects
Population

ASJC Scopus subject areas

  • Hematology

Cite this

Markert, M. L., Alexieff, M. J., Li, J., Sarzotti, M., Ozaki, D. A., Devlin, B. H., ... Skinner, M. A. (2004). Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood, 104(8), 2574-2581. https://doi.org/10.1182/blood-2003-08-2984

Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. / Markert, M. Louise; Alexieff, Marilyn J.; Li, Jie; Sarzotti, Marcelle; Ozaki, Daniel A.; Devlin, Blythe H.; Sedlak, Debra A.; Sempowski, Gregory D.; Hale, Laura P.; Rice, Henry E.; Mahaffey, Samuel M.; Skinner, Michael A.

In: Blood, Vol. 104, No. 8, 15.10.2004, p. 2574-2581.

Research output: Contribution to journalArticle

Markert, ML, Alexieff, MJ, Li, J, Sarzotti, M, Ozaki, DA, Devlin, BH, Sedlak, DA, Sempowski, GD, Hale, LP, Rice, HE, Mahaffey, SM & Skinner, MA 2004, 'Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome', Blood, vol. 104, no. 8, pp. 2574-2581. https://doi.org/10.1182/blood-2003-08-2984
Markert ML, Alexieff MJ, Li J, Sarzotti M, Ozaki DA, Devlin BH et al. Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. Blood. 2004 Oct 15;104(8):2574-2581. https://doi.org/10.1182/blood-2003-08-2984
Markert, M. Louise ; Alexieff, Marilyn J. ; Li, Jie ; Sarzotti, Marcelle ; Ozaki, Daniel A. ; Devlin, Blythe H. ; Sedlak, Debra A. ; Sempowski, Gregory D. ; Hale, Laura P. ; Rice, Henry E. ; Mahaffey, Samuel M. ; Skinner, Michael A. / Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome. In: Blood. 2004 ; Vol. 104, No. 8. pp. 2574-2581.
@article{9d91a97a4f6849c2abb9123a814d0d0b,
title = "Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome",
abstract = "Complete DiGeorge syndrome is a fatal congenital disorder characterized by athymia, hypoparathyroidism, and heart defects. Less than half of patients are 22q11 hemizygous. The goal of this study was to assess if immune suppression followed by postnatal thymus transplantation would lead to T-cell function in 6 infant patients who had host T cells at the time of transplantation. All infants had fewer than 50 recent thymic emigrants (CD3+CD45RA +CD62L+) per cubic millimeter (mm3) and all had some proliferative response to the mitogen phytohemagglutinin. Four infants had rash, lymphadenopathy, and oligoclonal populations of T cells in the periphery. Five of 6 patients are alive at the follow-up interval of 15 months to 30 months. The 5 surviving patients developed a mean of 983 host CD3+ T cells/ mm3 (range, 536/mm3-1574/mm3), a mean of 437 recent thymic emigrants/mm3 (range, 196/mm3-785/ mm3), and normal proliferative responses to phytohemaglutinin (follow-up from day 376 to day 873). The TCR repertoire became polyclonal in patients who presented with oligoclonal T cells. All patients had thymopoiesis on allograft biopsy. Postnatal thymus transplantation after treatment with Thymoglobulin shows promise as therapy for infants with complete DiGeorge syndrome who have significant proliferative responses to mitogens or who develop rash, lymphadenopathy, and oligoclonal T cells.",
author = "Markert, {M. Louise} and Alexieff, {Marilyn J.} and Jie Li and Marcelle Sarzotti and Ozaki, {Daniel A.} and Devlin, {Blythe H.} and Sedlak, {Debra A.} and Sempowski, {Gregory D.} and Hale, {Laura P.} and Rice, {Henry E.} and Mahaffey, {Samuel M.} and Skinner, {Michael A.}",
year = "2004",
month = "10",
day = "15",
doi = "10.1182/blood-2003-08-2984",
language = "English (US)",
volume = "104",
pages = "2574--2581",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "8",

}

TY - JOUR

T1 - Postnatal thymus transplantation with immunosuppression as treatment for DiGeorge syndrome

AU - Markert, M. Louise

AU - Alexieff, Marilyn J.

AU - Li, Jie

AU - Sarzotti, Marcelle

AU - Ozaki, Daniel A.

AU - Devlin, Blythe H.

AU - Sedlak, Debra A.

AU - Sempowski, Gregory D.

AU - Hale, Laura P.

AU - Rice, Henry E.

AU - Mahaffey, Samuel M.

AU - Skinner, Michael A.

PY - 2004/10/15

Y1 - 2004/10/15

N2 - Complete DiGeorge syndrome is a fatal congenital disorder characterized by athymia, hypoparathyroidism, and heart defects. Less than half of patients are 22q11 hemizygous. The goal of this study was to assess if immune suppression followed by postnatal thymus transplantation would lead to T-cell function in 6 infant patients who had host T cells at the time of transplantation. All infants had fewer than 50 recent thymic emigrants (CD3+CD45RA +CD62L+) per cubic millimeter (mm3) and all had some proliferative response to the mitogen phytohemagglutinin. Four infants had rash, lymphadenopathy, and oligoclonal populations of T cells in the periphery. Five of 6 patients are alive at the follow-up interval of 15 months to 30 months. The 5 surviving patients developed a mean of 983 host CD3+ T cells/ mm3 (range, 536/mm3-1574/mm3), a mean of 437 recent thymic emigrants/mm3 (range, 196/mm3-785/ mm3), and normal proliferative responses to phytohemaglutinin (follow-up from day 376 to day 873). The TCR repertoire became polyclonal in patients who presented with oligoclonal T cells. All patients had thymopoiesis on allograft biopsy. Postnatal thymus transplantation after treatment with Thymoglobulin shows promise as therapy for infants with complete DiGeorge syndrome who have significant proliferative responses to mitogens or who develop rash, lymphadenopathy, and oligoclonal T cells.

AB - Complete DiGeorge syndrome is a fatal congenital disorder characterized by athymia, hypoparathyroidism, and heart defects. Less than half of patients are 22q11 hemizygous. The goal of this study was to assess if immune suppression followed by postnatal thymus transplantation would lead to T-cell function in 6 infant patients who had host T cells at the time of transplantation. All infants had fewer than 50 recent thymic emigrants (CD3+CD45RA +CD62L+) per cubic millimeter (mm3) and all had some proliferative response to the mitogen phytohemagglutinin. Four infants had rash, lymphadenopathy, and oligoclonal populations of T cells in the periphery. Five of 6 patients are alive at the follow-up interval of 15 months to 30 months. The 5 surviving patients developed a mean of 983 host CD3+ T cells/ mm3 (range, 536/mm3-1574/mm3), a mean of 437 recent thymic emigrants/mm3 (range, 196/mm3-785/ mm3), and normal proliferative responses to phytohemaglutinin (follow-up from day 376 to day 873). The TCR repertoire became polyclonal in patients who presented with oligoclonal T cells. All patients had thymopoiesis on allograft biopsy. Postnatal thymus transplantation after treatment with Thymoglobulin shows promise as therapy for infants with complete DiGeorge syndrome who have significant proliferative responses to mitogens or who develop rash, lymphadenopathy, and oligoclonal T cells.

UR - http://www.scopus.com/inward/record.url?scp=1942538141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1942538141&partnerID=8YFLogxK

U2 - 10.1182/blood-2003-08-2984

DO - 10.1182/blood-2003-08-2984

M3 - Article

C2 - 15100156

AN - SCOPUS:1942538141

VL - 104

SP - 2574

EP - 2581

JO - Blood

JF - Blood

SN - 0006-4971

IS - 8

ER -